Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
Chemokines were initially identified as bioactive substances, which control the trafficking of inflammatory cells including granulocytes and monocytes/macrophages. Moreover, chemokines have profound impacts on other types of cells associated with inflammatory responses, such as endothelial cells and...
Saved in:
Main Authors: | Naofumi Mukaida, So-ichiro Sasaki, Tomohisa Baba |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/170381 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Inflammatory Chemokine CCL5 and Cancer Progression
by: Donatella Aldinucci, et al.
Published: (2014-01-01) -
Analysis of Progress and Challenges of EGFR-Targeted Molecular Imaging in Cancer With a Focus on Affibody Molecules
by: Weizhi Chen MD, et al.
Published: (2019-01-01) -
The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets
by: M. Isabel Palacios-Arreola, et al.
Published: (2014-01-01) -
RECK as a Potential Crucial Molecule for the Targeted Treatment of Sepsis
by: Qin Y, et al.
Published: (2025-02-01) -
The N1‐methyladenosine methyltransferase TRMT61A promotes bladder cancer progression and is targetable by small molecule compounds
by: Jianjian Yin, et al.
Published: (2025-01-01)